Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OR1M1 OR52K1 LILRA3 BMPR2 CD3E EDAR OR56B1 OR11A1 FCGR2A IL1R2 OPN3 OR9I1 IGHM OR5B17 OR1E1 NID1 OR8H1 PTGER4 F2RL2 AR OR6X1 OR9A2 EPHA3	1.65e-08	1353	89	23	GO:0004888
GeneOntologyMolecularFunction	olfactory receptor activity	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	2.20e-05	431	89	10	GO:0004984
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 AR OR6X1 OR9A2	3.47e-05	884	89	14	GO:0004930
GeneOntologyMolecularFunction	general transcription initiation factor binding	CAND1 MTOR MED1 AR	1.91e-04	64	89	4	GO:0140296
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	1.70e-05	432	89	10	GO:0050911
GeneOntologyBiologicalProcess	mature natural killer cell chemotaxis	XCL2 XCL1	1.84e-05	2	89	2	GO:0035782
GeneOntologyBiologicalProcess	positive regulation of CD4-positive, alpha-beta T cell proliferation	CD3E XCL2 XCL1	2.15e-05	13	89	3	GO:2000563
GeneOntologyBiologicalProcess	sensory perception of smell	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	3.19e-05	465	89	10	GO:0007608
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 PTPRQ OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	4.09e-05	582	89	11	GO:0050906
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	4.55e-05	485	89	10	GO:0050907
GeneOntologyBiologicalProcess	regulation of B cell chemotaxis	XCL2 XCL1	5.51e-05	3	89	2	GO:2000537
GeneOntologyBiologicalProcess	positive regulation of B cell chemotaxis	XCL2 XCL1	5.51e-05	3	89	2	GO:2000538
GeneOntologyBiologicalProcess	positive regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	5.51e-05	3	89	2	GO:2000558
GeneOntologyBiologicalProcess	regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	5.51e-05	3	89	2	GO:2000557
GeneOntologyBiologicalProcess	regulation of immunoglobulin production	FCGR2A IGHM XCL2 XCL1 IL33	5.70e-05	95	89	5	GO:0002637
GeneOntologyBiologicalProcess	detection of stimulus	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 PTPRQ OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	6.21e-05	722	89	12	GO:0051606
GeneOntologyBiologicalProcess	positive regulation of type 2 immune response	XCL2 XCL1 IL33	8.39e-05	20	89	3	GO:0002830
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR1M1 OR52K1 CD3E OR56B1 OR11A1 OPN3 OR9I1 OR5B17 XCL2 OR1E1 OR8H1 PTGER4 F2RL2 XCL1 AR OR6X1 OR9A2	8.47e-05	1395	89	17	GO:0007186
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	8.66e-05	524	89	10	GO:0009593
GeneOntologyBiologicalProcess	T-helper 1 type immune response	MTOR XCL2 XCL1 IL33	1.15e-04	58	89	4	GO:0042088
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	1.23e-04	547	89	10	GO:0007606
GeneOntologyBiologicalProcess	inorganic anion transport	SLC37A1 CLCA2 CLCNKB MTOR SLC34A2 SLC4A3	1.30e-04	180	89	6	GO:0015698
GeneOntologyBiologicalProcess	skeletal muscle hypertrophy	MTOR AR	1.83e-04	5	89	2	GO:0014734
GeneOntologyBiologicalProcess	positive regulation of thymocyte migration	XCL2 XCL1	1.83e-04	5	89	2	GO:2000412
GeneOntologyBiologicalProcess	immunoglobulin production in mucosal tissue	XCL2 XCL1	1.83e-04	5	89	2	GO:0002426
GeneOntologyBiologicalProcess	regulation of CD4-positive, alpha-beta T cell proliferation	CD3E XCL2 XCL1	2.35e-04	28	89	3	GO:2000561
GeneOntologyBiologicalProcess	negative regulation of interleukin-1 alpha production	IL1R2 PTGER4	2.73e-04	6	89	2	GO:0032690
GeneOntologyBiologicalProcess	regulation of thymocyte migration	XCL2 XCL1	2.73e-04	6	89	2	GO:2000410
GeneOntologyBiologicalProcess	maternal process involved in female pregnancy	BMPR2 MTOR MED1 AR	2.81e-04	73	89	4	GO:0060135
GeneOntologyBiologicalProcess	inorganic anion transmembrane transport	SLC37A1 CLCA2 CLCNKB MTOR SLC4A3	2.88e-04	134	89	5	GO:0098661
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell proliferation	CD3E XCL2 XCL1	2.90e-04	30	89	3	GO:0035739
GeneOntologyBiologicalProcess	positive regulation of alpha-beta T cell proliferation	CD3E XCL2 XCL1	3.20e-04	31	89	3	GO:0046641
GeneOntologyBiologicalProcess	skeletal muscle adaptation	MTOR CMYA5 AR	3.52e-04	32	89	3	GO:0043501
GeneOntologyBiologicalProcess	positive regulation of natural killer cell chemotaxis	XCL2 XCL1	3.81e-04	7	89	2	GO:2000503
GeneOntologyBiologicalProcess	mammary gland branching involved in pregnancy	MED1 AR	3.81e-04	7	89	2	GO:0060745
GeneOntologyBiologicalProcess	eosinophil migration	XCL2 PTGER4 XCL1	4.22e-04	34	89	3	GO:0072677
GeneOntologyBiologicalProcess	regulation of T-helper 1 type immune response	XCL2 XCL1 IL33	4.60e-04	35	89	3	GO:0002825
GeneOntologyBiologicalProcess	negative regulation of T-helper 1 type immune response	XCL1 IL33	5.07e-04	8	89	2	GO:0002826
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell activation	CD3E MTOR XCL2 PTGER4 XCL1	5.29e-04	153	89	5	GO:0035710
GeneOntologyBiologicalProcess	regulation of type 2 immune response	XCL2 XCL1 IL33	5.43e-04	37	89	3	GO:0002828
GeneOntologyBiologicalProcess	thymocyte migration	XCL2 XCL1	6.50e-04	9	89	2	GO:0072679
GeneOntologyBiologicalProcess	regulation of T-helper 1 cell cytokine production	XCL2 XCL1	6.50e-04	9	89	2	GO:2000554
GeneOntologyBiologicalProcess	positive regulation of T-helper 1 cell cytokine production	XCL2 XCL1	6.50e-04	9	89	2	GO:2000556
GeneOntologyBiologicalProcess	B cell chemotaxis	XCL2 XCL1	6.50e-04	9	89	2	GO:0035754
GeneOntologyBiologicalProcess	sensory perception	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 PTPRQ OR5B17 OR1E1 OR8H1 ALOXE3 TECTA OR6X1 OR9A2	6.69e-04	1072	89	13	GO:0007600
GeneOntologyBiologicalProcess	regulation of natural killer cell chemotaxis	XCL2 XCL1	8.10e-04	10	89	2	GO:2000501
GeneOntologyBiologicalProcess	positive regulation of T-helper 2 cell cytokine production	XCL2 XCL1	8.10e-04	10	89	2	GO:2000553
Domain	GPCR_Rhodpsn_7TM	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 OR6X1 OR9A2	1.46e-05	670	88	13	IPR017452
Domain	Olfact_rcpt	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	1.59e-05	393	88	10	IPR000725
Domain	7tm_1	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 OR6X1 OR9A2	1.63e-05	677	88	13	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 OR6X1 OR9A2	1.85e-05	685	88	13	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 OR6X1 OR9A2	2.03e-05	691	88	13	PS50262
Domain	GPCR_Rhodpsn	OR1M1 OR52K1 OR56B1 OR11A1 OPN3 OR9I1 OR5B17 OR1E1 OR8H1 PTGER4 F2RL2 OR6X1 OR9A2	2.06e-05	692	88	13	IPR000276
Domain	Chemokine_XCL1/XCL2	XCL2 XCL1	2.19e-05	2	88	2	IPR008105
Domain	TILa	ZAN TECTA	6.56e-05	3	88	2	PF12714
Domain	TILa_dom	ZAN TECTA	6.56e-05	3	88	2	IPR025615
Domain	fn3	NEO1 IGFN1 TNC COL14A1 CMYA5 EPHA3	1.17e-04	162	88	6	PF00041
Domain	NIDO_dom	NID1 TECTA	2.17e-04	5	88	2	IPR003886
Domain	NIDO	NID1 TECTA	2.17e-04	5	88	2	SM00539
Domain	NIDO	NID1 TECTA	2.17e-04	5	88	2	PF06119
Domain	NIDO	NID1 TECTA	2.17e-04	5	88	2	PS51220
Domain	FN3	NEO1 IGFN1 TNC COL14A1 CMYA5 EPHA3	2.41e-04	185	88	6	SM00060
Domain	FN3	NEO1 IGFN1 TNC COL14A1 CMYA5 EPHA3	3.56e-04	199	88	6	PS50853
Domain	FN3_dom	NEO1 IGFN1 TNC COL14A1 CMYA5 EPHA3	4.62e-04	209	88	6	IPR003961
Domain	Ig-like_fold	LILRA3 CD3E NEO1 IGFN1 FCGR2A IL1R2 TNC IGHM COL14A1 CMYA5 EPHA3	4.72e-04	706	88	11	IPR013783
Domain	IGc2	LILRA3 CD3E NEO1 IGFN1 FCGR2A IL1R2	8.54e-04	235	88	6	SM00408
Domain	Ig_sub2	LILRA3 CD3E NEO1 IGFN1 FCGR2A IL1R2	8.54e-04	235	88	6	IPR003598
Domain	-	LILRA3 CD3E NEO1 IGFN1 FCGR2A IL1R2 TNC COL14A1 CMYA5 EPHA3	1.11e-03	663	88	10	2.60.40.10
Domain	TIL	ZAN TECTA	1.40e-03	12	88	2	PF01826
Domain	C8	ZAN TECTA	1.40e-03	12	88	2	PF08742
Domain	Unchr_dom_Cys-rich	ZAN TECTA	1.66e-03	13	88	2	IPR014853
Domain	C8	ZAN TECTA	1.66e-03	13	88	2	SM00832
Domain	TIL_dom	ZAN TECTA	1.93e-03	14	88	2	IPR002919
Domain	VWD	ZAN TECTA	2.52e-03	16	88	2	SM00216
Domain	VWF_type-D	ZAN TECTA	2.52e-03	16	88	2	IPR001846
Domain	VWFD	ZAN TECTA	2.52e-03	16	88	2	PS51233
Domain	VWD	ZAN TECTA	2.52e-03	16	88	2	PF00094
Domain	EGF	ZAN TNC NID1 TECTA	2.98e-03	126	88	4	PF00008
Domain	VWC_out	ZAN TECTA	3.56e-03	19	88	2	SM00215
Domain	HEAT_REPEAT	CAND1 MTOR HEATR5A	4.41e-03	70	88	3	PS50077
Domain	SEA	MUC16 MUC12	4.77e-03	22	88	2	PF01390
Domain	Ig_2	LILRA3 NEO1 FCGR2A	4.96e-03	73	88	3	PF13895
Domain	SEA	MUC16 MUC12	5.21e-03	23	88	2	PS50024
Domain	SEA_dom	MUC16 MUC12	5.21e-03	23	88	2	IPR000082
Domain	Fibrinogen_a/b/g_C_2	TNC ANGPTL5	5.66e-03	24	88	2	IPR014715
Domain	-	TNC ANGPTL5	5.66e-03	24	88	2	4.10.530.10
Domain	Fibrinogen_C	TNC ANGPTL5	7.14e-03	27	88	2	PF00147
Domain	FBG	TNC ANGPTL5	8.20e-03	29	88	2	SM00186
Domain	EGF_2	ZAN TNC NID1 MUC12 EPHA3	8.34e-03	265	88	5	PS01186
Domain	IG_LIKE	LILRA3 CD3E NEO1 IGFN1 FCGR2A IL1R2 IGHM	8.47e-03	491	88	7	PS50835
Domain	-	TNC ANGPTL5	8.76e-03	30	88	2	3.90.215.10
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR1M1 OR52K1 OR56B1 CLCA2 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	3.08e-06	389	70	11	M14091
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	3.74e-05	417	70	10	M4072
Pubmed	Quorum sensing contributes to activated IgM-secreting B cell homeostasis.	CD3E FCGR2A IGHM	1.73e-07	5	91	3	23209322
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR1E1 OR8H1 OR6X1 OR9A2	2.85e-07	340	91	9	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR1E1 OR8H1 OR6X1 OR9A2	2.85e-07	340	91	9	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR1E1 OR8H1 OR6X1 OR9A2	3.06e-07	343	91	9	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR1E1 OR8H1 OR6X1 OR9A2	3.29e-07	346	91	9	14611657
Pubmed	Genetic control of NKT cell numbers maps to major diabetes and lupus loci.	FCGR2A XCL2 XCL1	9.61e-07	8	91	3	12960309
Pubmed	The human olfactory receptor gene family.	OR1M1 OR52K1 OR56B1 OR11A1 OR9I1 OR5B17 OR1E1 OR8H1 OR6X1 OR9A2	1.59e-06	541	91	10	14983052
Pubmed	Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin.	CD3E TNC NID1 IL33	3.02e-06	38	91	4	27653694
Pubmed	Structure and expression of two highly related genes encoding SCM-1/human lymphotactin.	XCL2 XCL1	6.77e-06	2	91	2	8849694
Pubmed	Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.	BMPR2 TNC	6.77e-06	2	91	2	16782755
Pubmed	Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.	XCL2 XCL1	6.77e-06	2	91	2	9834111
Pubmed	Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.	FCGR2A ALOX5AP	6.77e-06	2	91	2	31992246
Pubmed	EPHA3 enhances macrophage autophagy and apoptosis by disrupting the mTOR signaling pathway in mice with endometriosis.	MTOR EPHA3	6.77e-06	2	91	2	31262977
Pubmed	T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production.	XCL2 XCL1	6.77e-06	2	91	2	22528127
Pubmed	Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.	XCL2 XCL1	6.77e-06	2	91	2	25497737
Pubmed	Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.	XCL2 XCL1	6.77e-06	2	91	2	19097989
Pubmed	Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo.	XCL2 XCL1	6.77e-06	2	91	2	9029087
Pubmed	Gene Expression Studies to Identify Significant Genes in AR, MTOR, MAPK Pathways and their Overlapping Regulatory Role in Prostate Cancer.	MTOR AR	6.77e-06	2	91	2	31136301
Pubmed	Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer.	MTOR AR	6.77e-06	2	91	2	27350136
Pubmed	The systemic exercise-released chemokine lymphotactin/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation.	XCL2 XCL1	6.77e-06	2	91	2	31413355
Pubmed	The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy.	AR EPHA3	6.77e-06	2	91	2	30958616
Pubmed	The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study.	MTOR ALOXE3	6.77e-06	2	91	2	30678711
Pubmed	A genome-wide association scan implicates DCHS2, RUNX2, GLI3, PAX1 and EDAR in human facial variation.	DCHS2 EDAR	6.77e-06	2	91	2	27193062
Pubmed	The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAPM/PKA/mTORC1/rpS6 Pathway.	TNC PTGER4	6.77e-06	2	91	2	36078128
Pubmed	Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.	XCL2 XCL1	6.77e-06	2	91	2	12226740
Pubmed	Aberrant tissue positioning of metallophilic macrophages in the thymus of XCL1-deficient mice.	XCL2 XCL1	6.77e-06	2	91	2	24778093
Pubmed	Molecular cloning and functional characterization of human lymphotactin.	XCL2 XCL1	6.77e-06	2	91	2	7602097
Pubmed	Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.	AR IL33	6.77e-06	2	91	2	33964300
Pubmed	Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.	XCL2 XCL1	6.77e-06	2	91	2	11601972
Pubmed	The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.	MTOR IGHM	6.77e-06	2	91	2	24141387
Pubmed	Molecular cloning of a novel C or gamma type chemokine, SCM-1.	XCL2 XCL1	6.77e-06	2	91	2	7875320
Pubmed	Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.	MED1 AR	6.77e-06	2	91	2	22102282
Pubmed	In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.	XCL2 XCL1	6.77e-06	2	91	2	17990361
Pubmed	Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia.	XCL2 XCL1	6.77e-06	2	91	2	8757601
Pubmed	A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells.	XCL2 XCL1	6.77e-06	2	91	2	30542351
Pubmed	Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.	XCL2 XCL1	6.77e-06	2	91	2	14734774
Pubmed	T cells regulate lymph node-resident ILC populations in a tissue and subset-specific way.	CD3E IL33	6.77e-06	2	91	2	33665576
Pubmed	Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin.	XCL2 XCL1	6.77e-06	2	91	2	11181058
Pubmed	Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.	MAPKAP1 AR	2.03e-05	3	91	2	32088212
Pubmed	MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.	MTOR MUC16	2.03e-05	3	91	2	26046375
Pubmed	A Novel α9 Integrin Ligand, XCL1/Lymphotactin, Is Involved in the Development of Murine Models of Autoimmune Diseases.	XCL2 XCL1	2.03e-05	3	91	2	28550205
Pubmed	Murine lymphotactin: gene structure, post-translational modification and inhibition of expression by CD28 costimulation.	XCL2 XCL1	2.03e-05	3	91	2	9199871
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	2.03e-05	3	91	2	26770020
Pubmed	Differential contribution of the MTOR and MNK pathways to the regulation of mRNA translation in meiotic and postmeiotic mouse male germ cells.	MAPKAP1 MTOR	2.03e-05	3	91	2	20574055
Pubmed	Basal mTORC2 activity and expression of its components display diurnal variation in mouse perivascular adipose tissue.	MAPKAP1 MTOR	2.03e-05	3	91	2	27016480
Pubmed	CD3 and immunoglobulin G Fc receptor regulate cerebellar functions.	CD3E FCGR2A	2.03e-05	3	91	2	17502348
Pubmed	Identification of single C motif-1/lymphotactin receptor XCR1.	XCL2 XCL1	2.03e-05	3	91	2	9632725
Pubmed	Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice.	XCL2 XCL1	2.03e-05	3	91	2	20541533
Pubmed	The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells.	CD3E IGHM	2.03e-05	3	91	2	19767510
Pubmed	Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.	AR EPHA3	2.03e-05	3	91	2	29917167
Pubmed	The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile.	MAPKAP1 MTOR	2.03e-05	3	91	2	21876130
Pubmed	Morin Acts as a USP7 Inhibitor to Hold Back the Migration of Rheumatoid Arthritis Fibroblast-Like Synoviocytes in a "Prickle1-mTORC2" Dependent Manner.	MAPKAP1 MTOR	2.03e-05	3	91	2	34331380
Pubmed	mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel.	MAPKAP1 MTOR	2.03e-05	3	91	2	21757730
Pubmed	PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.	MAPKAP1 MTOR	2.03e-05	3	91	2	26293922
Pubmed	Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.	MTOR AR	2.03e-05	3	91	2	26506516
Pubmed	AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways.	MTOR AR	2.03e-05	3	91	2	36768370
Pubmed	Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy.	XCL2 XCL1	2.03e-05	3	91	2	27387353
Pubmed	Deficiency of mature B cells does not alter the atherogenic response to castration in male mice.	IGHM AR	2.03e-05	3	91	2	35902665
Pubmed	SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.	MTOR AR	2.03e-05	3	91	2	29784665
Pubmed	Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction.	MAPKAP1 MTOR	2.03e-05	3	91	2	21170086
Pubmed	Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2.	MAPKAP1 MTOR	2.03e-05	3	91	2	23684622
Pubmed	Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.	XCL2 XCL1	2.03e-05	3	91	2	19913446
Pubmed	Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.	MTOR AR	2.03e-05	3	91	2	28468774
Pubmed	The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.	MTOR AR	2.03e-05	3	91	2	28745319
Pubmed	Lymphotactin acts as an innate mucosal adjuvant.	XCL2 XCL1	2.03e-05	3	91	2	9973465
Pubmed	Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains.	MAPKAP1 MTOR	4.05e-05	4	91	2	23762398
Pubmed	Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.	MTOR AR	4.05e-05	4	91	2	23798432
Pubmed	Crucial roles of XCR1-expressing dendritic cells and the XCR1-XCL1 chemokine axis in intestinal immune homeostasis.	XCL2 XCL1	4.05e-05	4	91	2	27005831
Pubmed	Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age.	CD3E IGHM	4.05e-05	4	91	2	22216188
Pubmed	mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.	MAPKAP1 MTOR	4.05e-05	4	91	2	16919458
Pubmed	Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses.	MAPKAP1 MTOR	4.05e-05	4	91	2	22550181
Pubmed	Interleukin-33 primes mast cells for activation by IgG immune complexes.	FCGR2A IL33	4.05e-05	4	91	2	23071771
Pubmed	Molecular cloning of mXCR1, the murine SCM-1/lymphotactin receptor.	XCL2 XCL1	4.05e-05	4	91	2	10518929
Pubmed	Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation.	FCGR2A IL33	4.05e-05	4	91	2	24356538
Pubmed	Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A.	XCL2 XCL1	4.05e-05	4	91	2	9013979
Pubmed	Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea: IL1R2, NPR2, AR, SP140 Methylation and Clinical Phenotype.	IL1R2 AR	4.05e-05	4	91	2	26888452
Pubmed	Regulatory T Cell Stability and Migration Are Dependent on mTOR.	CD3E MTOR	4.05e-05	4	91	2	32839235
Pubmed	Developmental gene expression profiling along the tonotopic axis of the mouse cochlea.	TNC PTPRQ TECTA	5.41e-05	28	91	3	22808246
Pubmed	mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.	MAPKAP1 MTOR	6.74e-05	5	91	2	33378666
Pubmed	Maternal hyperglycemia inhibits pulmonary vasculogenesis during mouse fetal lung development by promoting GβL Ubiquitination-dependent mammalian target of Rapamycin assembly.	MAPKAP1 MTOR	6.74e-05	5	91	2	36927703
Pubmed	The target of rapamycin complex 2 controls dendritic tiling of Drosophila sensory neurons through the Tricornered kinase signalling pathway.	MAPKAP1 MTOR	6.74e-05	5	91	2	19875983
Pubmed	Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes.	FCGR2A IL1R2	6.74e-05	5	91	2	12363051
Pubmed	A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.	MAPKAP1 MTOR	6.74e-05	5	91	2	22343943
Pubmed	Lymphocytes support oval cell-dependent liver regeneration.	CD3E IGHM	6.74e-05	5	91	2	18684967
Pubmed	C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.	FCGR2A MTOR	6.74e-05	5	91	2	27221338
Pubmed	Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.	CD3E IGHM	6.74e-05	5	91	2	17875636
Pubmed	mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).	MAPKAP1 MTOR	6.74e-05	5	91	2	18925875
Pubmed	Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development.	XCL2 XCL1	6.74e-05	5	91	2	21300913
Pubmed	TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.	FCGR2A IGHM	6.74e-05	5	91	2	21859955
Pubmed	Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development.	TNC AR	6.74e-05	5	91	2	10409496
Pubmed	CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways.	MAPKAP1 MTOR	6.74e-05	5	91	2	31665642
Pubmed	The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C.	MAPKAP1 MTOR	6.74e-05	5	91	2	18566586
Pubmed	Neogenin mediates the action of repulsive guidance molecule.	NEO1 EPHA3	6.74e-05	5	91	2	15258590
Pubmed	Bacteria-Induced Group 2 Innate Lymphoid Cells in the Stomach Provide Immune Protection through Induction of IgA.	CD3E IL33	6.74e-05	5	91	2	32240600
Pubmed	Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor.	IGHM IL33	6.74e-05	5	91	2	27918564
Pubmed	Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.	PTGER4 IL33	6.74e-05	5	91	2	28341741
Pubmed	Molecular and cellular aspects of induced thymus development in recombinase-deficient mice.	XCL2 XCL1	6.74e-05	5	91	2	10458761
Pubmed	ER stress inhibits mTORC2 and Akt signaling through GSK-3β-mediated phosphorylation of rictor.	MAPKAP1 MTOR	6.74e-05	5	91	2	21343617
Pubmed	IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction.	IGHM IL33	6.74e-05	5	91	2	31591231
Pubmed	The genes encoding E-selectin (SELE) and lymphotactin (SCYC1) lie on separate chicken chromosomes although they are closely linked in human and mouse.	XCL2 XCL1	6.74e-05	5	91	2	11685458
GeneFamily	Fibronectin type III domain containing	NEO1 IGFN1 TNC PTPRQ COL14A1 CMYA5 EPHA3	1.87e-06	160	66	7	555
GeneFamily	MTOR complex 1\|MTOR complex 2	MAPKAP1 MTOR	1.30e-04	5	66	2	1333
GeneFamily	Solute carriers	SLC37A1 SLCO1C1 SLC6A19 SLC34A2 SLC25A44 SLC38A11 SLC4A3	5.79e-04	395	66	7	752
GeneFamily	CD molecules\|Mucins	MUC16 MUC12	2.64e-03	21	66	2	648
GeneFamily	Olfactory receptors, family 9	OR9I1 OR9A2	3.16e-03	23	66	2	156
GeneFamily	Fibrinogen C domain containing	TNC ANGPTL5	3.73e-03	25	66	2	554
Coexpression	SMID_BREAST_CANCER_LUMINAL_B_DN	CLCA2 IL1R2 TNC IGHM MUC16 SLC34A2 COL14A1 PTGER4 XCL1 IL33 PGBD5	5.44e-06	587	90	11	M17572
Coexpression	DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS	CD3E KCNQ5 IGHM XCL2 XCL1 ALOX5AP	1.10e-05	145	90	6	M40278
Coexpression	JIANG_MELANOMA_TRM11_CD8	XCL2 PTGER4 XCL1 ALOX5AP	2.45e-05	49	90	4	M48975
ToppCell	Healthy_Control-Lymphoid-NK-CD8_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CD3E TNC SPATA9 XCL2 F2RL2 XCL1	1.56e-06	174	91	6	5dddb822fa51b4020e4d9318acacd19c726091d6
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	DCHS2 SLCO1C1 NID1 COL14A1 SLC38A11 EPHA3	1.66e-06	176	91	6	2015539c58aa0bb118e111ffedd63dd9fe863bb1
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD3E SUN2 XCL2 PTGER4 XCL1 ALOX5AP	2.59e-06	190	91	6	ce049630ed69d31f00acbc1b5b0896efc592121f
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD3E KCNQ5 IGHM XCL2 XCL1 ALOX5AP	2.67e-06	191	91	6	beb15dcc6df156ab342fc21a60a874c868780ce4
ToppCell	moderate-Lymphoid-CTL\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CD3E SUN2 XCL2 PTGER4 XCL1 ALOX5AP	2.84e-06	193	91	6	3fce0807631811da1cff5ca9db23ff1ad36020e7
ToppCell	NS-moderate-d_16-33-Lymphoid-CTL\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CD3E SUN2 XCL2 PTGER4 XCL1 ALOX5AP	2.92e-06	194	91	6	6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288
ToppCell	Mild-CD8+_T\|World / Disease group and Cell class	CD3E SUN2 XCL2 HERC1 XCL1 ALOX5AP	2.92e-06	194	91	6	d64c2efb482bcdef9240977eae1023c4191286e7
ToppCell	NS-moderate-d_16-33\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CD3E FCGR2A IL1R2 XCL2 XCL1 ALOX5AP	3.10e-06	196	91	6	85301941e0c04a237b307f56c87dc06760015a5d
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC37A1 PTPRQ SLC34A2 ALOXE3 HEATR5A CSMD2	3.19e-06	197	91	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	wk_20-22-Hematologic_Lymphocytic\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 IGHM XCL2 XCL1 ALOX5AP	3.19e-06	197	91	6	77107345c766451302e21f7cbd45316f4131a0e8
ToppCell	wk_15-18-Hematologic_Lymphocytic\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 IGHM XCL2 XCL1 ALOX5AP	3.19e-06	197	91	6	af16598a87c21c626e97e277e2deff4882e3eda2
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD8\|GI_large-bowel / Manually curated celltypes from each tissue	CD3E SUN2 XCL2 PTGER4 XCL1 ALOX5AP	3.29e-06	198	91	6	9a1488d7e80a15a278f044fac09a4bcafa6800fe
ToppCell	(10)_CD8_T\|World / shred on Cell_type and subtype	CD3E SUN2 XCL2 PTGER4 XCL1 ALOX5AP	4.02e-06	205	91	6	87c36989d0fc926f36d6b911ede068455f027177
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	IGFN1 KCNQ5 PTPRQ PLCD4 NEB	1.67e-05	155	91	5	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD3E KIAA0825 XCL2 SLC38A11 XCL1	1.72e-05	156	91	5	8790b4b400695571fcf1ccb24c658b5e90854ff7
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNQ5 OR56B1 XCL2 XCL1 ALOX5AP	1.83e-05	158	91	5	607a13a3991953c1a98cc2fe90099b60487ca4f1
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	2.25e-05	165	91	5	207f9ca8839f54710e2112986def4bc7b0ef1a28
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|Endothelial_cells / Location, Cell class and cell subclass	CD3E GLS2 XCL2 PTGER4 ALOX5AP	2.67e-05	171	91	5	dcb6c41980008d0b9eeb54999faff77311554976
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCNQ5 COL14A1 SLC38A11 CSMD2 IL33	2.67e-05	171	91	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	NYNRIN IQCN HERC1 CMYA5 ANGPTL5	2.75e-05	172	91	5	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC37A1 CD3E KCNQ5 TNC PTGER4	2.75e-05	172	91	5	10a1d1838492b8ce6dea08844353b51571432c56
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	NYNRIN IQCN HERC1 CMYA5 ANGPTL5	2.75e-05	172	91	5	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC37A1 CD3E KCNQ5 TNC PTGER4	2.75e-05	172	91	5	d824e46c8040b0bb9235f9b8a2b35386b303caa0
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|356C / Donor, Lineage, Cell class and subclass (all cells)	BMPR2 CD3E KIAA0825 MTOR AR	2.82e-05	173	91	5	e3cb7c8c09f937da6b8d673e9adfec5d94a15548
ToppCell	356C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CD3E KIAA0825 XCL2 XCL1 ALOX5AP	3.15e-05	177	91	5	7ddd7d1854ad42abd630ad0c702105102cec93e7
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BMPR2 KIAA0825 MTOR IGHM AR	3.15e-05	177	91	5	36b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNC OPN3 SLC34A2 CSMD2 PGBD5	3.24e-05	178	91	5	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	356C-Lymphocytic-ILC-ILC-1\|356C / Donor, Lineage, Cell class and subclass (all cells)	CD3E KIAA0825 XCL2 XCL1 ALOX5AP	3.24e-05	178	91	5	40df4bb0978e5e5568c52ad4a5881ea0cdc6941d
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL14A1 CMYA5 ANGPTL5 IL33 EPHA3	3.32e-05	179	91	5	dcd0a83f0592ae27f814d064b4791f84c3c86e64
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PXMP2 PLCD4 NEB KLHL31	3.41e-05	180	91	5	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	356C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CD3E KIAA0825 XCL2 XCL1 ALOX5AP	3.41e-05	180	91	5	cedbe692c5257fb6f9a552e2f197163626ac17d9
ToppCell	droplet-Kidney-nan-3m-Hematologic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3E PTGER4 F2RL2 XCL1 PALB2	3.50e-05	181	91	5	58d7e76dfaa818aeaef7f129c4472bf5b6563218
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC37A1 CD3E XCL2 XCL1 ALOX5AP	3.50e-05	181	91	5	dd4126bf3c02e63866e2b3f2db81e3565f0e8c40
ToppCell	droplet-Kidney-nan-3m-Hematologic\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3E PTGER4 F2RL2 XCL1 PALB2	3.50e-05	181	91	5	5d76e99bf2b5b337041efd3cd33bebbb0637b64e
ToppCell	PCW_05-06-Immune_Lymphocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CD3E FCGR2A XCL2 XCL1 ALOX5AP	3.50e-05	181	91	5	bd99c5849bb4979c891898312cb9f602c6831b23
ToppCell	droplet-Kidney-nan-3m-Hematologic-leukocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3E PTGER4 F2RL2 XCL1 PALB2	3.50e-05	181	91	5	970fc90e27236ee30190f1a02f418a378919c60b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNC NID1 COL14A1 CMYA5 EPHA3	3.60e-05	182	91	5	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	CD3E IGHM XCL2 XCL1 ALOX5AP	3.60e-05	182	91	5	111d434b89902ec11fb07f41b8ee1a98f3991b61
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NID1 COL14A1 TECTA ANGPTL5 EPHA3	3.69e-05	183	91	5	06a68fa2be36448064f4668be24a5b85ad85c6e8
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	3.69e-05	183	91	5	2e36bbc241682e47e880be21c1503abd7d0c3082
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO1C1 PLCD4 SLC38A11 NEB KLHL31	3.69e-05	183	91	5	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLC37A1 CD3E KCNQ5 XCL1 ALOX5AP	3.79e-05	184	91	5	3e9d75af578297950e469f23fb2d28393a2feef8
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CD3E XCL2 XCL1 ALOX5AP PALB2	3.79e-05	184	91	5	17ffa0e890960c00a3b5fa33d48caba66c61dbb0
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DCHS2 CAND1 GLS2 SLC34A2 PALB2	3.79e-05	184	91	5	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	IGHM XCL2 XCL1	3.80e-05	32	91	3	f9624fe102388755e72d5a9a34afebaf77127961
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CD3E IGHM XCL2 XCL1 ALOX5AP	4.09e-05	187	91	5	9d298f43ae81d72091b31aaa6df41046d4aa31c5
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC37A1 CD3E XCL2 XCL1 ALOX5AP	4.09e-05	187	91	5	42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NEO1 TNC NID1 COL14A1 EPHA3	4.20e-05	188	91	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CD3E KCNQ5 XCL2 XCL1 ALOX5AP	4.31e-05	189	91	5	78dcda09109a5cfb04ba069f16ec80987b3ad432
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PXMP2 PLCD4 CMYA5 NEB KLHL31	4.31e-05	189	91	5	d2b008f98739c6af7ee63b643011a240db20e4d8
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD3E KCNQ5 XCL2 XCL1 ALOX5AP	4.41e-05	190	91	5	58f2278694931d4b104234810165715b510ab835
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 TNC NID1 COL14A1 PTGER4	4.41e-05	190	91	5	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 TNC NID1 COL14A1 PTGER4	4.41e-05	190	91	5	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	OPN3 IGHM SLC4A3 AR ALOX5AP	4.41e-05	190	91	5	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	PCW_10-12-Immune_Lymphocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CD3E IGHM XCL2 XCL1 ALOX5AP	4.41e-05	190	91	5	9b56763d62e1ed50006a5b90b160c5a82aab515b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 TNC NID1 COL14A1 PTGER4	4.53e-05	191	91	5	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CD3E XCL2 CATSPERB PTGER4 XCL1	4.53e-05	191	91	5	95ae42d145adb478d886a2259baacc713cd6587b
ToppCell	(0)_T_CD8\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.53e-05	191	91	5	59b87beec2b12ad0a35d86f911423e3a0a3f4701
ToppCell	PCW_07-8.5-Immune_Lymphocytic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD3E KCNQ5 XCL2 XCL1 ALOX5AP	4.53e-05	191	91	5	8911b88f70e5deed027177be2e6745b80308616b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 TNC NID1 COL14A1 PTGER4	4.64e-05	192	91	5	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-TRGV4_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.64e-05	192	91	5	f4b5a55a648e366234079411b6fdd2da75a4740e
ToppCell	NS-moderate-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.64e-05	192	91	5	ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNC OPN3 SLC34A2 CSMD2 PGBD5	4.64e-05	192	91	5	b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 TNC NID1 COL14A1 PTGER4	4.64e-05	192	91	5	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNC OPN3 SLC34A2 CSMD2 PGBD5	4.64e-05	192	91	5	b2d9cc2a013012b25b458d4dc77be63e1c2144da
ToppCell	ILEUM-non-inflamed-(1)_Cytotoxic_CD8_Trm\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.64e-05	192	91	5	cc9287803cd979e4b81f0649527f1b3bf54d0b83
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD3E KCNQ5 XCL2 XCL1 ALOX5AP	4.64e-05	192	91	5	6eadf0f37beae22838e930ad897a9b89e5e12cdb
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-CD56bright_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.64e-05	192	91	5	fedff776812c3d040d295ac8c806296e4018b247
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.87e-05	194	91	5	e9db509ff75f8605365841276fac6cec66ae27c7
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.87e-05	194	91	5	23174bfd1159619b2660f9bc07c99ba771f6a4e7
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-Intermediate_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.87e-05	194	91	5	54c809ed134ed828f3653603cf821cc303240f36
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.87e-05	194	91	5	c57cf3cc9fc1a682019090369fc1d3adbf37c371
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CD3E IGHM XCL2 XCL1 ALOX5AP	4.99e-05	195	91	5	4570644bcf8bbdfcd70f3cd8840eb94d3df383c8
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FCGR2A IL1R2 MUC16 COL14A1 CSMD2	4.99e-05	195	91	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8\|bone_marrow / Manually curated celltypes from each tissue	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.99e-05	195	91	5	ed4e2275dac47cc9fb9c381e3f80fed0ce50b074
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.99e-05	195	91	5	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FCGR2A IL1R2 MUC16 COL14A1 CSMD2	4.99e-05	195	91	5	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	wk_08-11-Hematologic_Lymphocytic\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CD3E IGHM XCL2 XCL1 ALOX5AP	4.99e-05	195	91	5	7f6ff1180c0be199c63dd049700d62dbc792b347
ToppCell	(0)_NK_T_CD8_Cytotoxic\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD3E XCL2 PTGER4 XCL1 ALOX5AP	4.99e-05	195	91	5	47efd6531a8421c733fabd905c71a7976d43f1ae
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-CD16+_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.99e-05	195	91	5	eadc2f8dd16d2b76c59b85f72905bd4b1545b560
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD3E SUN2 XCL2 XCL1 ALOX5AP	4.99e-05	195	91	5	730c613cf6f4d16ca51fd44de1f5a883f615c5c5
ToppCell	CV-Mild-0\|Mild / Virus stimulation, Condition and Cluster	CD3E SUN2 XCL2 PTGER4 XCL1	4.99e-05	195	91	5	2ffb9a9b6143bb404fe454cd939b573252bba6e9
ToppCell	(0)_NK/T_cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	baee29014dc56c71a6ef790bb7ecd5b5271cfcb0
ToppCell	critical-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CD3E SUN2 XCL2 XCL1 ALOX5AP	5.12e-05	196	91	5	c861f017aa9050282aa81c5a445bae399df00e4f
ToppCell	wk_20-22-Hematologic_Lymphocytic-NK-Intermediate_NK\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CD3E SUN2 XCL2 XCL1 ALOX5AP	5.12e-05	196	91	5	a2f938022a080202bce5bb157d13b86b69054468
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	530ac678d2be035e9e943302d51288cb810b3972
ToppCell	3'-Child09-12\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E SLC6A19 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	1bcc4ffff51cdb6211824686c2422c43b09e24b2
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	7369cf8edd3a4d7f911667bfd8d33062a0c7fb69
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CLCA2 TNC NYNRIN CMYA5 IL33	5.12e-05	196	91	5	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD3E SUN2 XCL2 PTGER4 XCL1	5.12e-05	196	91	5	a2607e972ff11d2e2fb8359e39605c236c0a1c63
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	a65d6a2d9eb3fca8faf323dbc4430e53134b7221
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD3E SUN2 XCL2 PTGER4 XCL1	5.12e-05	196	91	5	2fd2784c61f6dd17405f14ec2fd5d9a09e65a230
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.12e-05	196	91	5	349502ed53fbf365f8f6f9e27af7f421139ae169
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|Epithelial / Condition, Lineage and Cell class	CLCA2 NYNRIN MUC16 CMYA5 IL33	5.24e-05	197	91	5	78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD3E XCL2 PTGER4 XCL1 ALOX5AP	5.24e-05	197	91	5	44f9ea5c313fabb6e6a46c7b39f3cb924b8af1f4
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A	GLS2 IL1R2 TNC COL14A1 NEB F2RL2 SLC4A3 IL33	1.20e-06	198	90	8	5865_UP
Disease	pulmonary hypertension (implicated_via_orthology)	BMPR2 TNC MTOR ALOX5AP	1.73e-05	54	84	4	DOID:6432 (implicated_via_orthology)
Disease	asthma (is_marker_for)	BMPR2 FCGR2A TNC IL33 ALOX5AP	3.09e-05	126	84	5	DOID:2841 (is_marker_for)
Disease	lymphotactin measurement	XCL2 XCL1	4.79e-05	4	84	2	EFO_0008214
Disease	crescentic glomerulonephritis (implicated_via_orthology)	FCGR2A MTOR	1.19e-04	6	84	2	DOID:13139 (implicated_via_orthology)
Disease	survival time	XCL2 XCL1	2.85e-04	9	84	2	EFO_0000714
Disease	pleural tuberculosis (is_marker_for)	TNC IL33	3.55e-04	10	84	2	DOID:106 (is_marker_for)
Disease	Ankylosing spondylitis	IL1R2 PTGER4	4.33e-04	11	84	2	C0038013
Disease	common cold (is_marker_for)	IL33 ALOX5AP	6.12e-04	13	84	2	DOID:10459 (is_marker_for)
Disease	pulmonary hypertension (is_marker_for)	BMPR2 TNC ALOX5AP	8.18e-04	64	84	3	DOID:6432 (is_marker_for)
Disease	response to phenylephrine	F2RL2 NEK11	1.06e-03	17	84	2	EFO_0010152
Disease	ulcerative colitis (is_implicated_in)	FCGR2A PTGER4	1.06e-03	17	84	2	DOID:8577 (is_implicated_in)
Disease	osteoporosis (implicated_via_orthology)	PTGER4 AR	1.33e-03	19	84	2	DOID:11476 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC MTOR	1.33e-03	19	84	2	DOID:0080322 (biomarker_via_orthology)
Disease	end stage renal disease (implicated_via_orthology)	MTOR PTGER4	1.47e-03	20	84	2	DOID:783 (implicated_via_orthology)
Disease	Adenocarcinoma of prostate	AR PALB2	1.47e-03	20	84	2	C0007112
Disease	Inhalant adrenergic use measurement	MUC16 IL33 EMSY	2.63e-03	96	84	3	EFO_0009941
Disease	acute kidney failure (implicated_via_orthology)	MTOR PTGER4	2.68e-03	27	84	2	DOID:3021 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
YIKTISTTISPLLLI	ALOX5AP	146	P20292
ITDTYTQKLTVPTGL	SLC4A3	946	P48751
KTVVLPGYSSFLITS	CATSPERB	656	Q9H7T0
YILTGTSVPDLIVST	CSMD2	476	Q7Z408
VSYLGSISTLVTLPT	CEP68	496	Q76N32
IGYTLFSSKPVTITV	FCGR2A	191	P12318
TIGSVTKTPSGLYII	ANGPTL5	156	Q86XS5
PLYTTLGVITKGTVI	NSA2	206	O95478
TKTLLQTYPVVSVTL	IQCN	336	Q9H0B3
PSTKYLVISLVILSF	PCDHB1	686	Q9Y5F3
TIDFPLLTSLGKVSY	KIAA0895L	406	Q68EN5
ILATLATGKTVISYG	OR9I1	81	Q8NGQ6
RATLTTSVYTPTLGT	MUC16	10491	Q8WXI7
LSKVFSLLYTVVTPL	OR11A1	271	Q9GZK7
GKLTLSLYTIGSIIS	KLHL31	131	Q9H511
FTTLTTVPGVIRYKG	DRG1	96	Q9Y295
TLVILTSPLTELYKT	KIAA0825	736	Q8IV33
TKGTTTLKTYLDTLP	ALOXE3	616	Q9BYJ1
TITLTTIGYGDKTPL	KCNQ5	306	Q9NR82
ISTAGYSIPELLTKL	EDAR	401	Q9UNE0
ILAITTGTYADKLSP	HERC1	1821	Q15751
KVYPSSLSKISGSIL	CAND1	721	Q86VP6
LLGTLLVSPVTIATY	PTGER4	66	P35408
TAISTIPETVGYSLL	NID1	471	P14543
YPSIVTSSLILKATL	OR56B1	141	Q8NGI3
VSGSTAISTYPKTLI	NEK11	11	Q8NG66
STITLYITAPTLALT	MT-ND1	66	P03886
VKPLTYAISISTLGT	GLS2	221	Q9UI32
SGTLELPSTLSLYKS	AR	336	P10275
YTTTVIPKLLGTFVV	OR6X1	71	Q8NH79
PIYDATGKLLVTSTT	PTPRQ	1796	Q9UMZ3
IDSTTGIIYLTLPLS	DCHS2	821	Q6V1P9
GYLTSSLSTKLIPAI	F2RL2	86	O00254
TGLSSSILLYTPLNT	PALB2	696	Q86YC2
KNYIIFTGPSITSLT	PGBD5	336	Q8N414
VTPTISIVSYLFAKS	OPN3	286	Q9H1Y3
ALVSGPYTLITTAVS	SLC37A1	431	P57057
SPSKNYILSVISGSI	GLG1	1141	Q92896
SSITGISPITEYLAS	IL33	111	O95760
GSISILPTILYLTIG	HEATR5A	1741	Q86XA9
SGPTTYKVTSTLTIK	IGHM	171	P01871
KGLTPLTEYTIAIFS	COL14A1	591	Q05707
IPTTSTSVSEYLILA	CMYA5	1096	Q8N3K9
STSSSLLYPLIKLAV	BMPR2	701	Q13873
YKVSISGTTVILTCP	CD3E	36	P07766
GTNVTISSLKPDTIY	EPHA3	491	P29320
VGTVPVTTYTAKGLR	IGFN1	896	Q86VF2
YVKTTSGSIITVVPK	EMSY	531	Q7Z589
YAKLSTSSTLKVLPG	FAM186A	341	A6NE01
TYLTGVILGKTLSSE	HDAC8	316	Q9BY41
IGLSTVTFTLPLSLY	SLC38A11	101	Q08AI6
SVTIEGTSAVYKLPI	MED1	256	Q15648
VKSTLLLYQSPTTGL	PHKB	56	Q93100
LVVTGAYSKPTLSAL	LILRA3	116	Q8N6C8
LSYIISLTSGLSSLP	NYNRIN	1411	Q9P2P1
YSSAVTPKVLTGLLI	OR5B17	71	Q8NGF7
YIISTILKIPSASGR	OR9A2	216	Q8NGT5
LSFIDLSYSTVITPK	OR8H1	66	Q8NGG4
LSYSTVITPKTLANL	OR8H1	71	Q8NGG4
GSYARIVSSILKVPS	OR1E1	216	P30953
IGVYLCPSSVLTTVK	OR1M1	256	Q8NGA1
PLHYTTVLTGSLITK	OR52K1	131	Q8NGK4
ALIYPLTVASKSTTT	MTOR	1971	P42345
IETTGKAVYITSTLP	SLC6A19	216	Q695T7
PALSSLVIYLKSVSF	PLCD4	491	Q9BRC7
LYSSLVTAGPASKII	TMEM191A	81	Q9H0A3
ATVTSYLKLLLAPSS	MOV10	801	Q9HCE1
TTLSYLVTGLKPNTL	NEO1	911	Q92859
LEKSVSIYTPVVSLS	SPDL1	501	Q96EA4
GVTALSVYLTPKTSD	SHKBP1	376	Q8TBC3
TLALVEKYSSPGLTS	MAPKAP1	261	Q9BPZ7
TPSTIVIVVGYESLK	SLC25A44	286	Q96H78
YGFSPVLKTLTESVS	PIGC	131	Q92535
ISFPAKTALTSIIYA	SPATA9	136	Q9BWV2
ISYPQILTLSTSGVL	IL1R2	136	P27930
LLSIIGYNTTSTVPK	SERINC1	291	Q9NRX5
LVSYLPTTVSAKTDI	CLCA2	376	Q9UQC9
ATSKPVYSALATLVL	CLCNKB	321	P51801
TKIELLPSYSTATLI	SLC34A2	46	O95436
VPFITGLATKIYSSE	TECTA	1571	O75443
PVSRIKTYTITEGSL	XCL1	41	P47992
PVSRIKTYTITEGSL	XCL2	41	Q9UBD3
TYETKTALLSLFGIP	SUN2	566	Q9UH99
LYPVLTKAATSGILS	PXMP2	31	Q9NR77
GKPISSSASVKIIYV	SMC1B	71	Q8NDV3
VISVITSYTLSLGGI	SLCO1C1	556	Q9NYB5
VYLSGLAPSIRTKTI	TNC	1506	P24821
LTPKFYVALTGTSSL	ST7L	76	Q8TDW4
STKDISVYSVLGLPA	PITPNM3	841	Q9BZ71
VKPEYLTLLVSGTTA	PTGR3	146	Q8N4Q0
LTLLVSGTTAYISLK	PTGR3	151	Q8N4Q0
VSVAGLSVTKPYVIT	ZNF181	41	Q2M3W8
LSKVYVTLPESTVTL	ZAN	1211	Q9Y493
TATTPGLSAKSTILY	MUC12	4871	Q9UKN1
VKATSYILPSSTLSL	NEB	4711	P20929